Application Information

This drug has been submitted to the FDA under the reference 022387/001.

Names and composition

"TYVASO" is the commercial name of a drug composed of TREPROSTINIL.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022387/001 TYVASO TREPROSTINIL SOLUTION/INHALATION 0.6MG per ML

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021272/001 REMODULIN TREPROSTINIL INJECTABLE/IV (INFUSION), SUBCUTANEOUS 1MG per ML
021272/002 REMODULIN TREPROSTINIL INJECTABLE/IV (INFUSION), SUBCUTANEOUS 2.5MG per ML
021272/003 REMODULIN TREPROSTINIL INJECTABLE/IV (INFUSION), SUBCUTANEOUS 5MG per ML
021272/004 REMODULIN TREPROSTINIL INJECTABLE/IV (INFUSION), SUBCUTANEOUS 10MG per ML
022387/001 TYVASO TREPROSTINIL SOLUTION/INHALATION 0.6MG per ML
203649/001 TREPROSTINIL TREPROSTINIL INJECTABLE/INJECTION 1MG per ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved